Cases 1 - 5 of 5
UCB, Inc. et al v. Mylan Technologies Inc.
as 2:2022cv00216
Plaintiff:
UCB, Inc., UCB Pharma GmbH and LTS Lohmann Therapie-Systeme AG
Defendant:
Mylan Technologies Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UCB, Inc. et al v. Mylan Technologies, Inc. et al
as 2:2019cv00148
Plaintiff:
UCB, Inc., LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH and others
Defendant:
Mylan Pharmaceuticals, Inc., Mylan Technologies, Inc. and Mylan, Inc.
Counter Claimant:
Mylan Technologies Inc.
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc.
as 2:2019cv00128
Plaintiff:
UCB Pharma GmbH, UCB, Inc. and LTS Lohmann Therapie-Systeme AG
Defendant:
Mylan Technologies, Inc.
Cause Of Action: 35 U.S.C. § 271
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al
as 5:2011cv00050
Plaintiff:
Vivelle Ventures LLC , Novern Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation
Defendant:
Mylan Technologies, Inc., Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 271
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al
as 1:2011cv01187
Plaintiff:
Vivelle Ventures LLC , Noven Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation
Defendant:
Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan Pharmaceuticals, Inc. , Mylan, Inc. and Mylan Technologies, Inc.
Counter_defendant:
Novartis Pharmaceuticals Corporation , Noven Pharmaceuticals, Inc. and Vivelle Ventures LLC
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
